tamoxifen and glp-1 SABCS 2025: Can GLP-1s Help People With Breast Cancer? GLP-1 Drugs and Breast Cancer:

Pregnancy, breastfeeding, and immunocompromised states also warrant provider assessment

Cycle Guidelines Common Retatrutide + MOTS-c Cycle Approaches Approach Conservative starter Duration Reta weeks 1-24 (titrate to 4-6 mg max) MOTS-c Pattern MOTS-c only weeks 5-12, then off Best For First-time stack users, metabolic concerns Approach Standard research cycle Duration Reta weeks 1-48 (target 9 mg) MOTS-c Pattern MOTS-c 8-week pulses with 4-week breaks Best For Most community protocols Approach Aggressive deficit Duration Reta weeks 1-68 (target 12 mg) MOTS-c Pattern MOTS-c 6 weeks on / 2 weeks off, repeating Best For Advanced subjects with established tolerance Retatrutide is run open-ended in clinical trials (TRIUMPH-4 lasted 68 weeks)

Metropolitan population health trends show rising obesity prevalence correlated with lifestyle changes and increased cardiovascular disease risk

However, it significantly elevates cortisol and prolactin, creating metabolic complications

M (1998)